Practices for Preventing Polypharmacy in Multiple Sclerosis

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Ahmed Z. Obeidat, MD, PhD Guest: Lauren Beranek, BS Polypharmacy is defined as the regular use of five or more prescribed medications, and due to their disease course, related symptoms, and side effects, patients with multiple sclerosis are at an increased risk of polypharmacy. So to hear insights on ways to identify, manage, and prevent polypharmacy, Dr. Mary Catherine Cheeley is joined by Dr. Ahmed Obeidat, Associate Professor of Neurology, and Lauren Beranek, MD candidate at the Medical College of Wisconsin. Find a full article on their findings published in Practical Neurology.